Infectious Diseases COVID-19 Guillain-Barré Syndrome HIV/AIDS Chronic Diseases Cancer Management Vaccines Neurodegenerative Conditions Encephalitis Chronic Wasting Disease Overcrowding Risks Cancer Treatment Respiratory Illnesses Neurodegenerative Diseases Respiratory Issues Foot and Mouth Disease Vaccination Hansen's Disease Guillain-Barre Syndrome Chronic Disease Funding Allocation Primary Amoebic Meningoencephalitis Sickle Cell Anaemia Asthma Management Chronic Conditions Influenza Flu Diagnosis Vector-Borne Diseases HIV Awareness Bleeding Disorders Healthcare Professionals Treatment Protocols Cardiovascular Health Liver Diseases Cognitive Decline Epidemiological Studies Q-fever Health Recovery Avian Influenza Winter Illnesses Diarrhoea Flu Season Cancer Covid-19 Snakebite Treatment Thalassemia Heart Failure Health Alerts Avian Diseases Mortality Analysis Vector Control Osteoarthritis
The decision is intended to accelerate WHO prequalification and national registrations for rapid rollout in endemic settings.
